Sonata's founding membership costs $2,500 a year. The company displays $4,000 as the regular annual price and says founding members can keep the lower rate while their membership remains active.[1][2][3]
That price covers considerably more than a large blood panel. Sonata combines whole-genome sequencing, more than 140 blood biomarkers, DNA methylation testing, wearable and medical-record data, and unlimited access to a physician-led care team. Board-certified doctors remain responsible for diagnosis, prescribing, treatment decisions, and the member's care plan.[1]
Several boundaries matter. Sonata does not accept insurance, does not provide emergency or urgent care, and charges separately for some advanced testing. Its genetic risk scores and biological-age measurement also sit at different levels of clinical maturity. A familiar cholesterol result and a DNA methylation age are both health data, but physicians do not use them with the same degree of standardization.
Here is what the membership includes, where the evidence is established, and what to ask before paying for a year.
What Is Sonata Health?
Sonata is a doctor-led preventive-care company available in New York, San Francisco, and Los Angeles. It launched publicly on July 14, 2026, with a model that combines advanced testing and ongoing medical care.[1]
The company is trying to solve a real consumer problem. People can buy genetic tests, lab panels, biological-age estimates, and wearable devices from separate vendors. Each product produces another report or dashboard. Sonata puts those inputs in one record and gives physicians responsibility for interpreting them together.
Members begin with an in-home or workplace blood draw. Whole-genome sequencing and the rest of the initial testing take about three to four weeks. The care team then reviews the results, medical history, wearables, and stated goals before building a personalized plan. Members can contact the team for follow-ups and questions throughout the year.[2]
The plan may include medication, supplements, nutrition, fitness, repeat testing, or a specialist referral. Sonata physicians can prescribe when clinically appropriate, including common medications, hormone therapy, and glucagon-like peptide-1 (GLP-1) drugs. The company says every prescription remains a physician's clinical decision.[1][2]
What the Sonata Membership Includes
The founding rate covers the following services:[1][2][3]
Included service | What Sonata says it provides | What to clarify before joining |
|---|---|---|
Physician-led care | Unlimited visits or access throughout the year | Whether you consistently see the same physician and how quickly the team responds |
In-home blood draw | Initial specimen collection at home or work | Whether repeat draws and follow-up tests are included |
Whole-genome sequencing | Clinical-grade sequencing intended to guide care | Which findings are returned and whether genetic counseling is available |
Polygenic risk scores | Risk estimates across 19 common conditions | How ancestry affects accuracy and which results change medical management |
Blood testing | More than 140 biomarkers, including hormones and lipids | Which tests repeat during the year and which advanced tests cost extra |
DNA methylation | Biological age and pace-of-aging measurement | Which clock is used and what clinical decision changes because of the result |
Data integration | Medical records, wearables, lifestyle, and laboratory results in one view | Which wearables connect and how records are shared with outside doctors |
Personalized plan | Recommendations that evolve as results and goals change | How progress is measured and when the plan is reviewed |
New York members also have access to dual-energy X-ray absorptiometry (DEXA) and metabolic testing, according to the company's FAQ.[2] Sonata does not say on that page whether every New York member receives those tests at no additional charge, so that is worth confirming.
The annual membership does not automatically cover every possible test. Sonata says some advanced testing costs extra.[2] Patients should request a written list of included baseline tests, included repeats, and common add-on prices before enrolling.
Who Founded Sonata?
Sagan Schultz, MD, MBA, and David Deng founded Sonata in 2025, according to AlleyWatch. The company launched publicly the following July.[1][4]
Schultz serves as chief executive officer. Sonata's launch announcement describes him as the first product manager at Linear and a former McKinsey healthcare consultant. Deng, the chief technology officer, previously worked as one of Ramp's first ten engineers and on Flatiron Health's clinical-genomics team.[1]
Their backgrounds explain the product's structure. Schultz brings medical training, healthcare consulting, and consumer-software product experience. Deng brings software infrastructure and clinical-genomics experience. Sonata built its own clinical artificial intelligence (AI) system to organize the incoming data, while physicians retain responsibility for clinical decisions.[1]
How was Sonata Health Funded?
Sonata has raised $7 million in venture backing from Lux Capital, BoxGroup, Sunflower Capital, and unnamed founders and operators associated with Linear and Ramp. It appears that Lux led a seed round of the investment. [1]
The Clinical Core: Ongoing Physician Interpretation
A long test list can be useful, but the durable part of Sonata's offer is the doctor who decides what deserves action.
Blood pressure, fasting glucose, hemoglobin A1c, cholesterol, liver enzymes, and other conventional measurements already have established roles in clinical care. Their meaning still depends on age, symptoms, medication, family history, prior results, and the reason for testing. A mildly abnormal value may call for a repeat measurement rather than treatment. A result within a laboratory reference range may still matter when it has changed substantially from the patient's baseline.
Sonata's physicians can combine those conventional signals with records and follow-up. That is more useful than receiving a static lab report with every result labeled green or red. The value depends on execution: whether the same clinician follows the member, whether abnormal findings receive timely confirmation, and whether the care team coordinates effectively with specialists.
Patients comparing the price with membership medicine should read NextMD's 2026 concierge-pricing guide. Sonata's $2,500 founding rate sits just below NextMD's $3,000 lower boundary for the broad concierge market, while its $4,000 list price falls within the entry-level tier.
Whole-Genome Sequencing Can Produce Both Answers and Uncertainty
Whole-genome sequencing reads far more of a person's DNA than a test that examines a handful of variants. It can identify certain pathogenic variants that affect screening, medication, or family members. The National Human Genome Research Institute says genetic results may help doctors recommend earlier monitoring or other risk-reduction steps.[5]
Sequencing also produces findings whose meaning is unclear. The institute defines a variant of uncertain significance as a genetic change for which available evidence cannot establish whether it causes disease. It notes that uncertainty is more common in populations underrepresented in genomic research.[6]
Sonata's physician-led design gives it a better framework for handling these results than a report-only consumer test. The unanswered details are important. Prospective members should ask:
Which genes and secondary findings will Sonata report?
Does a certified genetics professional review clinically important results?
Are positive findings confirmed in a separate clinical laboratory before treatment changes?
Will Sonata reanalyze the stored sequence as scientific classifications change?
Can members download their raw and interpreted genomic data?
Those questions determine whether sequencing becomes a useful medical record or an expensive source of unresolved risk.
Polygenic Risk Scores Are Promising, but Still Developing
A single-gene variant can substantially affect the risk of certain inherited conditions. Common diseases such as coronary artery disease and type 2 diabetes usually involve many genetic and non-genetic factors. A polygenic risk score combines the estimated effects of many variants into one statistical risk measure.
Sonata calculates these scores across 19 conditions.[3] The technology can separate groups with higher and lower genetic susceptibility, but translating that ranking into better health outcomes remains difficult.
A systematic review of polygenic risk scores found evidence of clinical validity for some conditions but did not find unequivocal evidence that using the scores improved patient outcomes. The authors concluded that more translational research was needed before routine mainstream use.[7] Other research has highlighted ancestry-related performance differences because the underlying genetic datasets have historically overrepresented people of European ancestry.[6][7]
The practical test is whether a score changes care beyond established information. Ask the physician what recommendation would differ because of the polygenic result. A score that changes the timing of validated screening may be useful. A score that only adds a colored gauge to an app has much less value.
Biological Age Is Better Treated as a Research-Adjacent Signal
Sonata measures biological age and pace of aging through DNA methylation. Methylation describes chemical marks on DNA that influence how genes are regulated. Researchers have developed mathematical clocks that use these patterns to estimate aspects of aging.
The field has produced associations between accelerated methylation age and health outcomes. A 2026 review also found limited generalizability, unclear causal mechanisms, inconsistent longitudinal performance, and a lack of standardized protocols. The authors described methylation clocks as promising while noting that they are not routinely used in clinical practice.[8]
That distinction should shape expectations. A biological-age result may help track a research-adjacent signal over time. It does not tell a patient exactly how long they will live, and a change in the number does not by itself prove that a supplement, diet, or exercise plan prevented disease.
Ask Sonata which methylation clock it uses, what normal test-to-test variation looks like, and which clinical decision depends on the result. The answer should be more specific than trying to make the age number go down.
Is Sonata Primary Care or Concierge Medicine?
Sonata describes itself as a preventive-care practice. It says the service becomes the main preventive-care relationship for some members, while others keep their existing primary-care doctor and use Sonata alongside that physician. Sonata can prescribe, arrange referrals, and exchange records with outside providers.[2]
The service does not provide emergency or urgent care.[2] Prospective members should ask how Sonata handles same-day illness, vaccinations, routine physical examinations, after-hours questions, hospital follow-up, and care while traveling. Those answers determine whether a separate primary-care relationship remains necessary.
Traditional concierge primary care usually centers on one physician who manages both prevention and everyday medical needs. NextMD's canonical benchmarks are $3,000 to over $40,000 a year, panels under 300 patients per physician, and appointments lasting 30 to 60 minutes or more. Our concierge medicine versus direct primary care comparison explains the broader model differences.
Sonata is currently available in three markets with deep concierge supply. Patients can compare its testing-centered model with physician-led practices across the New York City metro, San Francisco, and the Los Angeles metro. For example, HealthspanSF is a NextMD-listed San Francisco practice that also emphasizes longevity and whole-genome analysis within a physician-led relationship.
What Sonata's Price Does Not Answer
The founding rate is competitive with entry-level concierge care, particularly because it includes whole-genome sequencing and a large initial test set. Price alone cannot establish value. Four operational questions will decide whether the membership earns its cost.
Continuity: Unlimited access may mean repeated contact with one doctor or communication with a rotating care team. Patients paying for longitudinal interpretation should know which model applies.
Follow-up: A risk finding creates value only when the next step is appropriate. Ask who orders confirmatory tests, whether those tests cost extra, and who coordinates a specialist referral.
Scope: Sonata clearly excludes urgent and emergency care. Its public FAQ does not fully describe every routine primary-care service. Get the clinical scope in writing before replacing an existing physician relationship.
Evidence: Sonata launched publicly in July 2026. We found no peer-reviewed outcome study of the complete Sonata membership during our review. The company provides testimonials and explains the scientific literature behind its tools, but those materials do not establish that the full program prevents more disease or improves longevity compared with high-quality primary care.
A pilot randomized trial illustrates the broader evidence problem. Adding whole-genome sequencing to primary care produced new molecular findings and more clinical actions, but many findings had uncertain utility. The researchers concluded that sequencing could reveal useful information while also prompting follow-up of unclear value.[9]
Seven Questions to Ask Before Joining
Who will be my doctor? Ask for the physician's name, board certification, state license, and expected continuity.
Which services replace primary care? Confirm coverage for acute illness, annual exams, vaccines, routine prescriptions, referrals, and hospital follow-up.
Which tests repeat at no extra charge? Separate the initial package from ongoing monitoring and paid add-ons.
How are genetic findings confirmed? Ask about laboratory standards, genetic counseling, secondary findings, and reanalysis.
What action follows each risk score? A useful result should connect to a validated screening or treatment decision.
How is health data handled? Review the privacy terms for genomic data, AI processing, outside laboratories, research use, deletion, and data export.
Can I use health savings account funds? Sonata accepts health savings account (HSA) and flexible spending account (FSA) cards and can provide an itemized invoice, but says eligibility depends on the member's plan. Confirm eligibility with the plan administrator before paying.[2]
The Bottom Line
Sonata combines two products that are often sold separately: a broad preventive-testing package and an ongoing physician relationship. The $2,500 founding price includes more clinical access than a report-only testing service, while the board-certified physician layer gives the data a path into actual care.
The membership also combines tools at different stages of maturity. Conventional biomarkers and physician follow-up have established clinical roles. Certain genomic findings can be actionable. Polygenic scores and methylation-based biological age require more careful interpretation, and neither should be treated as a guaranteed forecast.
Sonata may fit a healthy, data-oriented patient who wants extensive testing and will ask disciplined questions about follow-up. It may be a weaker fit for someone seeking comprehensive everyday primary care, urgent access, insurance billing, or proof that every included measurement improves health outcomes.
The decision comes down to responsibility. Ask who will interpret an abnormal result, confirm it, act on it, and stay involved afterward. A long list of tests becomes healthcare only when those four steps are clear.
FAQ
How much does Sonata Health cost?
Sonata's founding membership costs $2,500 per year. Its website displays $4,000 as the regular annual price and says founding members can keep the promotional rate while their membership remains active. Some advanced tests cost extra.[2][3]
Does Sonata accept insurance?
No. Sonata currently operates outside insurance. Members pay directly. The company accepts HSA and FSA cards, but eligibility depends on the member's plan.[2]
Is Sonata a primary-care practice?
Sonata calls itself a preventive-care practice and says it becomes the main preventive relationship for some members. It can prescribe and coordinate referrals, but it does not provide emergency or urgent care. Ask for a complete list of routine and acute services before treating it as a replacement for primary care.[2]
What tests are included with Sonata?
The membership includes whole-genome sequencing, polygenic risk scores across 19 conditions, DNA methylation-based biological-age measurement, more than 140 blood biomarkers, and integration of medical-record and wearable data. New York members also have access to DEXA and metabolic testing.[2][3]
Who founded Sonata?
Sagan Schultz, MD, MBA, and David Deng founded the company in 2025. Schultz is chief executive officer and Deng is chief technology officer. Sonata launched publicly in July 2026.[1][4]
Is Sonata venture-backed?
Yes. Sonata's launch announcement names Lux Capital, BoxGroup, Sunflower Capital, and founders and operators from Linear and Ramp as backers. AlleyWatch reported that the company raised $7 million in venture funding. The public sources reviewed do not identify a lead investor, round stage, valuation, individual angel investors, or each backer's contribution.[1][4]
Has Sonata proven that its membership improves health outcomes?
We found no peer-reviewed study of the complete Sonata membership as of July 17, 2026. Research supports clinical uses for some individual components, while the utility of broad genomic screening, polygenic scores, and biological-age clocks continues to develop.[7][8][9]
Compare Physician-Led Preventive Care
Advanced testing can reveal a risk. A durable physician relationship determines what happens next. NextMD is a free directory of physician-led concierge and direct primary care practices across the United States. Search by city, compare prices, and review doctor credentials.
Sources
SONATA. (2026, July 14). SONATA launches as a new doctor-led preventive healthcare membership bridging the gap between deep testing and personalized care. PR Newswire. Read the launch announcement
SONATA. (2026). Your questions, answered. Read the membership FAQ
SONATA. (2026). Membership overview and testing menu. View Sonata's membership pricing and review Sonata's testing menu
AlleyWatch. (2026, July 14). The AlleyWatch startup daily funding report: 7/14/2026. Read the funding report
National Human Genome Research Institute. (2019). Genetic testing FAQ. National Institutes of Health. Read the genetic-testing overview
National Human Genome Research Institute. (2026). Variant of uncertain significance. National Institutes of Health. Read the genetics glossary entry
Wand H, Lambert SA, Tamburro C, et al. (2022). The clinical utility of polygenic risk scores in genomic medicine practices: A systematic review. Human Genetics and Genomics Advances. Read the systematic review
Chen X, Cheng Q, Ji X. (2026). DNA methylation and prediction of biological age. Frontiers in Molecular Biosciences. Read the review
Vassy JL, Christensen KD, Schonman EF, et al. (2017). The impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients: A pilot randomized trial. Annals of Internal Medicine. Read the trial